Hovione Technology Develops Blister-Based Inhaler
Enabling Technologies Advance Poorly Soluble Highly Potent APIs
Pharma Facilities Still Have a Lot to Learn
Filling the Early Intermediate Security Gap
Regulating Cannabis-Based Medicines in Europe
Supply Chain Risk and Security Maturity Evolution
Looking Beyond the Solubility Horizon
Enhancing Bioavailability with Hot-Melt Extrusion
Leveraging Computational Models of Glycosylation for Biopharma QA
FDA Advances New Approach to Drug Quality Assessment
Considering Connected Inhalation Drug Delivery
Quality Agreements and Out-of-Specification Investigations
Putting Drug Delivery into Patients’ Hands